197 results on '"Gosney, John R."'
Search Results
2. Immunohistochemistry for prediction of response to immunotherapy
3. Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry
4. Machine-learning-based image analysis algorithms improve interpathologist concordance when scoring PD-L1 expression in non-small-cell lung cancer
5. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia
6. ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question—to treat or not to treat?
7. Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report
8. Improving practice in PD-L1 testing of non-small cell lung cancer in the UK: current problems and potential solutions.
9. Machine-learning-based image analysis algorithms improve interpathologist concordance when scoring PD-L1 expression in non-small-cell lung cancer.
10. Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey
11. Supplementary Table 7 from DNA Methylation Biomarkers Offer Improved Diagnostic Efficiency in Lung Cancer
12. Data from DNA Methylation Biomarkers Offer Improved Diagnostic Efficiency in Lung Cancer
13. Supplementary Table 8 from DNA Methylation Biomarkers Offer Improved Diagnostic Efficiency in Lung Cancer
14. Supplementary Table 6 from DNA Methylation Biomarkers Offer Improved Diagnostic Efficiency in Lung Cancer
15. Supplementary Table 4 from DNA Methylation Biomarkers Offer Improved Diagnostic Efficiency in Lung Cancer
16. Supplementary Table 2 from DNA Methylation Biomarkers Offer Improved Diagnostic Efficiency in Lung Cancer
17. Supplementary Table 5 from DNA Methylation Biomarkers Offer Improved Diagnostic Efficiency in Lung Cancer
18. Supplementary Table 3 from DNA Methylation Biomarkers Offer Improved Diagnostic Efficiency in Lung Cancer
19. Supplementary Table 1 from DNA Methylation Biomarkers Offer Improved Diagnostic Efficiency in Lung Cancer
20. The effect of time changes in diagnosing lung cancer type on its recorded distribution, with particular reference to adenocarcinoma
21. Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry
22. Improving practice in PD-L1 testing of non-small cell lung cancer in the UK: current problems and potential solutions
23. COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer
24. MesobanK UK: an international mesothelioma bioresource
25. Biomarker Testing for People With Advanced Lung Cancer in England
26. BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas
27. Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines
28. Making Light of an Interstitial Process
29. Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)
30. UHRF1-Mediated Tumor Suppressor Gene Inactivation in Nonsmall Cell Lung Cancer
31. Cellular pathology in the COVID-19 era: a European perspective on maintaining quality and safety
32. Reply to Scoring of PD‐L1 positivity: Are we analyzing enough cells?
33. Cytology for PD-L1 testing: A systematic review
34. Programmed death ligand 1 expression in EBUS aspirates of non–small cell lung cancer: Is interpretation affected by type of fixation?
35. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease
36. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia as a Precursor to Pulmonary Neuroendocrine Tumors*
37. Three different subsite classification systems for carcinomas in the proximity of the GEJ, but is it all one disease?
38. An Unusual Cause of Multiple Pulmonary Nodules: Glomus Tumors of the Lung
39. Loss of heterozygosity on chromosome 17p predicts neoplastic progression in Barrettʼs esophagus
40. Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response
41. Identification, morphology and secretory products of the pulmonary endocrine system
42. Endocrine differentiation in pulmonary neoplasms
43. Physiology of the pulmonary endocrine system
44. Introduction
45. Development and distribution of the pulmonary endocrine system
46. Pathology of pulmonary endocrine neoplasms
47. Paraneoplastic effects of pulmonary endocrine neoplasms
48. The pulmonary endocrine system in experimental injury
49. Serum markers of pulmonary endocrine neoplasms
50. The pulmonary endocrine system in diseased lungs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.